Clinical Trial Update: Theranova Randomized, Controlled, Trial (RCT) in China [NA]

View source ↗

Summary

A randomized controlled trial evaluating Theranova in China has completed, and the results were posted on 2024-10-15. The sponsor listed is Vantive Health LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Injury

Drugs mentioned

• Theranova

Snippet

Sponsor: Vantive Health LLC | Conditions: Chronic Kidney Failure, Acute Kidney Failure | NA | Status: COMPLETED | Results posted: 2024-10-15